Dr. Atri is an internationally renowned cognitive neurologist, and clinical researcher and trialist in Alzheimer’s disease (AD) and Related Dementias (ADRD). He is the Director of the Banner Sun Health Research Institute, Sun City, AZ; and Co-leader of the Clinical and Biomarker Cores of the NIA/NIH-funded Arizona Alzheimer’s Disease Research Center (ADRC). Dr. Atri holds degrees from the University of CA, Los Angeles (UCLA, Ph.D. Biomathematics), University of CA, San Francisco (UCSF, M.D.) and Harvard Medical School (HMS-MIT HST, M.M.Sc.). He completed internship (medicine) and residency (neurology) at the Harvard Massachusetts General Hospital (MGH)-Brigham and Women’s hospital programs; post-graduate training and clinical and research fellowships at MGH/HMS (Cognitive Neurology & Dementias), Boston University (Cognitive & Computational Neuroscience) and Massachusetts Institute of Technology (MIT Experimental Therapeutics); and served on the MGH faculty from 2001-2015. He continues to serve on the faculty at Brigham and Women’s Hospital (BWH) and Harvard Medical School (HMS), Boston, MA, USA. He specializes in the care of persons with early-onset cognitive disorders/young-onset AD/ADRD. His research and educational efforts focus on improving detection, prognostication, biomarker validation, experimental therapeutics and clinical best practices in ADRD. Dr. Atri serves as co-chair of the U.S. Alzheimer’s Association national clinical practice guidelines workgroup on the evaluation of suspected cognitive-behavioral impairment and AD/ADRD, as chair of the Alzheimer’s Disease International (ADI) Medical Scientific Advisory Panel, as Project Arm Leader for DIAN-TU001 gantenerumab OLE study, and has led and serves on steering committees of multiple global AD experimental therapeutics/trials programs and research consortia.